SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-069003
Filing Date
2020-06-02
Accepted
2020-06-02 16:49:13
Documents
19
Period of Report
2020-06-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2020765-3_8k.htm   iXBRL 8-K 32036
2 EXHIBIT 1.1 tm2020765d3_ex1-1.htm EX-1.1 221143
3 EXHIBIT 5.1 tm2020765d3_ex5-1.htm EX-5.1 48924
4 EXHIBIT 99.1 tm2020765d3_ex99-1.htm EX-99.1 11149
5 EXHIBIT 99.2 tm2020765d3_ex99-2.htm EX-99.2 11144
9 GRAPHIC tm2020765d3_ex5-1img001.jpg GRAPHIC 11190
10 GRAPHIC tm2020765d3_ex99-1img001.jpg GRAPHIC 24972
11 GRAPHIC tm2020765d3_ex99-2img001.jpg GRAPHIC 24972
  Complete submission text file 0001104659-20-069003.txt   659848

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA adap-20200601.xsd EX-101.SCH 3195
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE adap-20200601_lab.xml EX-101.LAB 34591
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE adap-20200601_pre.xml EX-101.PRE 22716
13 EXTRACTED XBRL INSTANCE DOCUMENT tm2020765-3_8k_htm.xml XML 3690
Mailing Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX
Business Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX 44 1235 430000
Adaptimmune Therapeutics PLC (Filer) CIK: 0001621227 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37368 | Film No.: 20937768
SIC: 2836 Biological Products, (No Diagnostic Substances)